BCAAs could be more beneficial for advanced liver fibrosis patients whose serum ALB levels are decreased due to reduced mTORC1 signaling in hepatocytes (Takegoshi et al., 2017). The gene discussed is ALB; the disease is Hepatic fibrosis.